Clinical Trial Update: Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating an anti-fibrinolytic for symptomatic mild traumatic brain injury in older adults is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Anti-fibrinolytic (unspecified)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Traumatic Brain Injury | Phase 3 | Status: RECRUITING